Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
NAMS, NAMSW | NewAmsterdam Pharma Co N.V. | Chief Commercial Officer | $1.1M | Jan 7, 2025 | ||
APGE | Apogee Therapeutics, Inc. | Director | $592K | Jun 5, 2024 | ||
AKLI | Akili, Inc. | Director | May 2, 2023 | |||
ANNX | Annexon, Inc. | Director | Jan 9, 2025 | |||
BHVN | Biohaven Pharmaceutical Holding Co Ltd. | CCO-Migraine & Common Disease | Oct 3, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|